Does IgE Have a Role in Aspirin-exacerbated Respiratory Disease?

被引：9
作者：
Busse, William W. [1 ]
机构：
[1] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI 53706 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2020年 / 201卷 / 12期
关键词：
OMALIZUMAB;
D O I：
10.1164/rccm.202003-0783ED
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：1459 / 1460
页数：3
相关论文
共 11 条
  • [1] Aspirin sensitivity: Lessons in the regulation (and dysregulation) of mast cell function
    Boyce, Joshua A.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 144 (04) : 875 - 881
  • [2] Prostaglandin D2: A dominant mediator of aspirin-exacerbated respiratory disease
    Cahill, Katherine N.
    Bensko, Jillian C.
    Boyce, Joshua A.
    Laidlaw, Tanya M.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (01) : 245 - 252
  • [3] Omalizumab in Severe Allergic Asthma Inadequately Controlled With Standard Therapy A Randomized Trial
    Hanania, Nicola A.
    Alpan, Oral
    Hamilos, Daniel L.
    Condemi, John J.
    Reyes-Rivera, Irmarie
    Zhu, Jin
    Rosen, Karin E.
    Eisner, Mark D.
    Wong, Dennis A.
    Busse, William
    [J]. ANNALS OF INTERNAL MEDICINE, 2011, 154 (09) : 573 - 582
  • [4] Omalizumab for Aspirin Hypersensitivity and Leukotriene Overproduction in Aspirin-exacerbated Respiratory Disease A Randomized Controlled Trial
    Hayashi, Hiroaki
    Fukutomi, Yuma
    Mitsui, Chihiro
    Kajiwara, Keiichi
    Watai, Kentaro
    Kamide, Yosuke
    Nakamura, Yuto
    Hamada, Yuto
    Tomita, Yasuhiro
    Sekiya, Kiyoshi
    Tsuburai, Takahiro
    Izuhara, Kenji
    Wakahara, Keiko
    Hashimoto, Naozumi
    Hasegawa, Yoshinori
    Taniguchi, Masami
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201 (12) : 1488 - 1498
  • [5] Omalizumab reduces cysteinyl leukotriene and 9α,11β-prostaglandin F2 overproduction in aspirin-exacerbated respiratory disease
    Hayashi, Hiroaki
    Mitsui, Chihiro
    Nakatani, Eiji
    Fukutomi, Yuma
    Kajiwara, Keiichi
    Watai, Kentaro
    Sekiya, Kiyoshi
    Tsuburai, Takahiro
    Akiyama, Kazuo
    Hasegawa, Yoshinori
    Taniguchi, Masami
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (05) : 1585 - 1587
  • [6] Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)a EAACI position paper
    Kowalski, Marek L.
    Agache, Ioana
    Bavbek, Sevim
    Bakirtas, Arzu
    Blanca, Miguel
    Bochenek, Grazyna
    Bonini, Matteo
    Heffler, Enrico
    Klimek, Ludger
    Laidlaw, Tanya M.
    Mullol, Joaquim
    Nizankowska-Mogilnicka, Ewa
    Park, Hae-Sim
    Sanak, Marek
    Sanchez-Borges, Mario
    Sanchez-Garcia, Silvia
    Scadding, Glenis
    Taniguchi, Masami
    Torres, Maria J.
    White, Andrew A.
    Wardzynska, Aleksandra
    [J]. ALLERGY, 2019, 74 (01) : 28 - 39
  • [7] Aspirin-Exacerbated Respiratory Disease - New Prime Suspects
    Laidlaw, Tanya M.
    Boyce, Joshua A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (05) : 484 - 488
  • [8] Omalizumab can inhibit respiratory reaction during aspirin desensitization
    Lang, David M.
    Aronica, Mark A.
    Maierson, Elizabeth S.
    Wang, Xiao-Feng
    Vasas, Dorothy C.
    Hazen, Stanley L.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (01) : 98 - 104
  • [9] MacGlashan DW, 1997, J IMMUNOL, V158, P1438
  • [10] Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria
    Maurer, Marcus
    Rosen, Karin
    Hsieh, Hsin-Ju
    Saini, Sarbjit
    Grattan, Clive
    Gimenez-Arnau, Ana
    Agarwal, Sunil
    Doyle, Ramona
    Canvin, Janice
    Kaplan, Allen
    Casale, Thomas
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (10) : 924 - 935
12